Category Biology/Biotechnology

Serotonin produced by gut bacteria provides hope for a novel IBS treatment

Newly revealed role of gut bacteria provides hope for a novel IBS treatment
Graphical abstract. Credit: Cell Reports (2025). DOI: 10.1016/j.celrep.2025.116434

Research from the University of Gothenburg, Sweden, clarifies the complex interaction between gut bacteria and irritable bowel syndrome (IBS). Experiments demonstrate that gut bacteria can produce the important substance serotonin. The finding may lead to future treatments.

IBS is a common gastrointestinal disorder, more common in women, with symptoms such as abdominal pain, constipation or diarrhea. The cause of the disease is not clear, but the intestinal environment, including the gut microbiota and serotonin, appear to be important factors.

Serotonin is best known as a neurotransmitter in the brain, but over 90% of the body’s serotonin is produced in the gut, where it controls bowel movements...

Read More

Drug combo cuts risk of death in advanced prostate cancer by 40%, clinical trial finds

male patient
Credit: Unsplash/CC0 Public Domain

Men whose prostate cancer returns after surgery or radiation therapy may now benefit from a new drug combination shown in clinical trials to cut the risk of death by more than 40%.

The combination therapy, which adds a drug called enzalutamide to commonly prescribed hormone therapy, reduced deaths in patients with recurrent prostate cancer after surgery or radiation for whom other treatments are no longer an option.

The trial results were published in The New England Journal of Medicine with simultaneous presentation during the European Society for Medical Oncology Congress (ESMO) Oct. 19 in Berlin.

“After initial treatment, some patients see their prostate cancer come back in an aggressive way and are at risk for their disease to spread quic...

Read More

How bacteria in tumors drive treatment resistance in cancer

Study reveals how bacteria in tumors drive treatment resistance in cancer
Graphical abstract. Credit: Cancer Cell (2025). DOI: 10.1016/j.ccell.2025.09.010

Researchers from The University of Texas MD Anderson Cancer Center have discovered a previously unknown mechanism that explains how bacteria can drive treatment resistance in patients with oral and colorectal cancer. The study was published today in Cancer Cell.

Tumor-infiltrating bacteria have been known to impact cancer progression and treatment, but very little is understood about how they do this. The new study shows how certain bacteria—particularly Fusobacterium nucleatum (Fn)—can induce a reversible state, known as quiescence, in cancer epithelial cells. This allows tumors to evade the immune system and resist chemotherapy.

“These bacteria-tumor interactions have been hiding in plain sig...

Read More

A hitchhiker’s guide to the galaxy of space immunology

A hitchhiker's guide to the galaxy of space immunology
In space, weakened immune function elevates disease risk. Continuous monitoring and targeted interventions are being proposed to protect astronaut immune health, while preventive measures aim to minimize long-term immune compromise. Credit: Huixan Du, Buck Institute for Research on Aging

With the advent of commercial spaceflight, an increasing number of people may be heading into space in the coming years. Some will even get a chance to fly to the moon or live on Mars.

One of the major health risks associated with spaceflight involves the immune system, which normally fights off viruses and cancer. It’s already established that spaceflight weakens immunity; current and past astronauts report clinical issues such as respiratory illnesses and skin rashes...

Read More